About Lynxdx

About company

LynxDx is a privately held pre-revenue diagnostic company headquartered in Ann Arbor, Michigan, with research facilities just a few miles away from the University of Michigan Health System. LynxDx currently is focused on commercializing diagnostic tools, including a diagnostic qPCR assay for COVID-19 and a urine assay to aid in the diagnosis of prostate cancer (MyProstateScore). LynxDx currently operates a CLIA-licensed high-complexity molecular diagnostics laboratory that serves to commercially provide its diagnostic assays.